share_log

賽生藥業:自願公告 - 達佑澤(那西妥單抗)於中國商業化上市

SCICLONE PHARMA: VOLUNTARY ANNOUNCEMENT - COMMERCIAL LAUNCH OF DANYELZA (NAXITAMAB) IN CHINA

香港交易所 ·  Jul 2, 2023 06:38
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more